möglich sobald bei der ZB eingereicht worden ist.
Neuroendocrine gut-brain signaling in obesity.
Trends Endocrinol. Metab., DOI: 10.1016/j.tem.2024.05.002 (2024)
The past decades have witnessed the rise and fall of several, largely unsuccessful, therapeutic attempts to bring the escalating obesity pandemic to a halt. Looking back to look ahead, the field has now put its highest hopes in translating insights from how the gastrointestinal (GI) tract communicates with the brain to calibrate behavior, physiology, and metabolism. A major focus of this review is to summarize the latest advances in comprehending the neuroendocrine aspects of this so-called 'gut-brain axis' and to explore novel concepts, cutting-edge technologies, and recent paradigm-shifting experiments. These exciting insights continue to refine our understanding of gut-brain crosstalk and are poised to promote the development of additional therapeutic avenues at the dawn of a new era of antiobesity therapeutics.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Schlagwörter
Glp1 ; Brainstem ; Gut–brain Axis ; Obesity ; Oxytocin ; Vagus Nerve
ISSN (print) / ISBN
1043-2760
e-ISSN
1879-3061
Zeitschrift
Trends in Endocrinology and Metabolism
Verlag
Elsevier
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Diabetes and Obesity (IDO)